NP-313, 2-Acetylamino-3-chloro-1,4-naphthoquinone, a Novel Antithrombotic Agent with Dual Inhibition of Thromboxane A(2) Synthesis and Calcium Entry.
Heng-Lan Kuo,Jin-Cherng Lien,Chien-Hsin Chang,Ching-Hu Chung,Sheng-Chu Kuo,Chun-Chieh Hsu,Hui-Chin Peng,Tur-Fu Huang
DOI: https://doi.org/10.1111/j.1476-5381.2011.01200.x
IF: 7.3
2011-01-01
British Journal of Pharmacology
Abstract:BACKGROUND AND PURPOSE1,4-Naphthoquinones exhibit antiplatelet activity both in vivo and in vitro. In the present study, we investigated the antiplatelet effect of a novel naphthoquinone derivative NP-313, 2-acetylamino-3-chloro-1,4-naphthoquinone and its mechanism of action.EXPERIMENTAL APPROACHWe measured platelet aggregation, Ca2+ mobilization, thromboxane B-2 formation and P-selectin expression and examined several enzymatic activities. Furthermore, we used the irradiated mesenteric venules in fluorescein sodium-treated mice to monitor the antithrombotic effect of NP-313 in vivo.KEY RESULTSNP-313 concentration-dependently inhibited human platelet aggregation induced by collagen, arachidonic acid, thapsigargin, thrombin and A23187. NP-313 also inhibited P-selectin expression, thromboxane B-2 formation and [Ca2+](i) elevation in platelets stimulated by thrombin and collagen. NP-313 at 10 mu M inhibited cyclooxygenase, thromboxane A(2) synthase, and protein kinase C alpha, whereas it did not affect phospholipase A(2) or phospholipase C activity. In the presence of indomethacin and an adenosine 5-diphosphate scavenger, NP-313 concentration-dependently inhibited thrombin-and A23187-induced [Ca2+](i) increase through its inhibitory effects on Ca2+ influx, rather than blocking Ca2+ release from intracellular stores. NP-313 also inhibited thapsigargin-mediated Ca2+ influx through store-operated calcium channel but had no effect on Ca2+ influx through store-independent calcium channel evoked by the diacylglycerol analogue 1-oleoyl-2-acetyl-sn-glycerol. Nevertheless, it had little effect on cyclic AMP and cyclic GMP levels. Also, intravenously administered NP-313 dose-dependently inhibited the thrombus occlusion of the irradiated mesenteric vessels of fluorescein-pretreated mice.CONCLUSIONS AND IMPLICATIONSTaken together, these results indicate that NP-313 exerts its antithrombotic activity through dual inhibition of thromboxane A(2) synthesis and Ca2+ influx through SOCC.